Cellromax Science Co., Ltd. Logo

Cellromax Science Co., Ltd.

Researches and develops health foods, derma-cosmetics, and OTC pharmaceuticals.

471820 | KO

Overview

Corporate Details

ISIN(s):
KR7471820001
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 구성로 357 D동 710호 (청덕동, 용인테크노밸리), 용인시

Description

Cellromax Science Co., Ltd. is a company specializing in the research, development, and manufacturing of health-related products. Its portfolio is centered on three key areas: health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company leverages scientific research and high-quality, naturally derived ingredients to create unique and effective products. Its development philosophy emphasizes optimized formulas and specialized prescriptions designed to support consumer health, skin vitality, and overall well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
현금ㆍ현물배당결정 (분기배당)
Korean 8.1 KB
2025-09-12 00:00
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.5 KB
2025-09-01 00:00
감자완료
Korean 8.9 KB
2025-08-27 00:00
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-13 00:00
[기재정정]주요사항보고서(감자결정)
Korean 22.5 KB
2025-08-12 00:00
[기재정정]전환청구권행사 (제1회차)
Korean 11.8 KB
2025-07-23 00:00
임시주주총회결과
Korean 5.6 KB
2025-07-22 00:00
전환청구권행사 (제1회차)
Korean 8.7 KB
2025-07-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-07-10 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-07-09 00:00
현금ㆍ현물배당결정 (분기배당)
Korean 8.8 KB
2025-07-09 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 35.5 KB
2025-07-08 00:00
주주총회소집공고
Korean 58.7 KB
2025-07-07 00:00
신탁계약해지결과보고서
Korean 35.1 KB
2025-06-13 00:00
수시공시의무관련사항(공정공시) (주주가치 제고를 위한 주주환원계획 수립)
Korean 8.8 KB

Automate Your Workflow. Get a real-time feed of all Cellromax Science Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cellromax Science Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cellromax Science Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.